Fein: PBM Drug Spending Rose Only 2% in 2018
Drug Channels Institute CEO Adam Fein in a review of 2018 reports by four pharmacy benefit managers found a 2 percent… Read more
HEOR Feature
Featured
Panel at ISPOR 2019 Discusses Role of ICER
The split views on the Institute for Clinical and Economic Review (ICER) were on display during a panel discussion at the International Society for… Read more
White Paper Spotlights Medical Affairs Support for Migraine Brands
A recent report by FirstView looks at the medical affairs support for 13 brand migraine medications, including Aimovig, Ajovy, Amerge and… Read more
Gottlieb Returns to Venture Capital Firm
Former Food and Drug Administration Commissioner Scott Gottlieb is back with venture capital firm New Enterprise Associates, Axios reports.
Gottlieb… Read more
